Close

Ratings by WBB Securities

Date Analyst CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
2/10/2022 Steve Brozak Paratek Pharmaceuticals PRTK Upgrade Strong Buy
(Speculative Buy)
11.00
(N/A)
3.97
(1.93)
-51.39% Details
2/2/2022 Steve Brozak ContraFect Corp. CFRX Upgrade Buy
(Hold)
6.50
(N/A)
2.93
(2.33)
-20.48% Details
65 more...